Oscar Health, Inc. (NYSE:OSCR) Stock Has Consensus Target Price of $33.90 According to Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR) have been assigned an average rating of “Hold” from the thirteen ratings firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, eight have assigned a hold rating, three have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $33.90.

A number of research analysts have issued reports on the company. The Goldman Sachs Group reissued a “neutral” rating and issued a $34.00 price target on shares of Oscar Health in a report on Thursday, September 17th. Bank of America raised their price objective on shares of Oscar Health from $28.00 to $30.00 and gave the stock an “underperform” rating in a research note on Thursday, September 17th. Barclays lifted their target price on shares of Oscar Health from $39.00 to $49.00 and gave the company an “overweight” rating in a report on Thursday, September 17th. Robert W. Baird boosted their target price on shares of Oscar Health from $27.00 to $33.00 and gave the company a “neutral” rating in a research note on Thursday, September 17th. Finally, Zacks Research upgraded shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th.

Oscar Health Price Performance

Shares of OSCR opened at $29.83 on Tuesday. The business’s 50-day moving average is $30.77 and its two-hundred day moving average is $25.13. The company has a market capitalization of $9.21 billion, a P/E ratio of 21.31, a P/E/G ratio of 0.34 and a beta of 2.47. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. Oscar Health has a fifty-two week low of $10.69 and a fifty-two week high of $34.48.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. The business had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The company’s revenue was up 70.4% on a year-over-year basis. During the same quarter last year, the business posted ($0.89) EPS. Research analysts predict that Oscar Health will post 1.83 earnings per share for the current year.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Janet Liang sold 10,360 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $325,822.00. Following the sale, the insider directly owned 248,697 shares of the company’s stock, valued at approximately $7,821,520.65. This trade represents a 4.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Blackley sold 28,869 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $907,930.05. Following the completion of the sale, the chief financial officer owned 1,046,108 shares of the company’s stock, valued at $32,900,096.60. This trade represents a 2.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 874,451 shares of company stock worth $26,761,671 over the last quarter. Company insiders own 22.64% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in OSCR. CoreCap Advisors LLC increased its holdings in Oscar Health by 526.3% in the 2nd quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock worth $34,000 after acquiring an additional 1,000 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Oscar Health by 32.9% during the 2nd quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock worth $41,000 after purchasing an additional 357 shares during the last quarter. FNY Investment Advisers LLC acquired a new position in shares of Oscar Health during the second quarter valued at approximately $57,000. Allworth Financial LP raised its holdings in shares of Oscar Health by 124.9% during the second quarter. Allworth Financial LP now owns 2,031 shares of the company’s stock valued at $58,000 after acquiring an additional 1,128 shares during the last quarter. Finally, IFP Advisors Inc lifted its position in shares of Oscar Health by 69.5% in the second quarter. IFP Advisors Inc now owns 2,139 shares of the company’s stock valued at $61,000 after acquiring an additional 877 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc is a technology-driven health insurance company that provides health plans and related services to individuals, families and businesses in the United States. The company primarily serves members through plans offered under the Affordable Care Act (ACA), including individual and family coverage purchased through government marketplaces.

Oscar’s offerings include medical insurance plans with access to provider networks, prescription drug coverage and member support services.